Hester Biosciences Ltd Q2 FY2023 consolidated profit up QoQ at Rs. 6.94 crores

Hester Biosciences Limited has reported Consolidated financial results for the period ended September 30, 2022.

Financial Results (Q2 FY2023) - QoQ Comparison

The company has reported total income of Rs. 77.602 crores during the period ended September 30, 2022 as compared to Rs. 53.818 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs. 6.942 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 3.968 crores for the period ended June 30, 2022.

The company has reported EPS of Rs. 7.77 for the period ended September 30, 2022 as compared to Rs. 4.18 for the period ended June 30, 2022.

Financials	Q2 FY2023	Q1 FY2023	% Change
Total Income	₹ 77.602 crs	₹53.818 crs	44.19%
Net Profit	₹6.942 crs	₹3.968 crs	74.95%
EPS	₹7.77	₹4.18	85.89%

Financial Results (Q2 FY2023) - YoY Comparison

The company has reported total income of Rs. 77.602 crores during the period ended September 30, 2022 as compared to Rs.64.086 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.6.942 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.10.623 crores for the period ended September 30, 2021.

The company has reported EPS of Rs.7.77 for the period ended September 30, 2022 as compared to Rs.13.08 for the period ended September 30, 2021.

Financials	Q2 FY2023	Q2 FY2022	% Change
Total Income	₹ 77.602 crs	₹64.086 crs	21.09%
Net Profit	₹6.942 crs	₹10.623 crs	-34.65%
EPS	₹7.77	₹13.08	-40.60%

Financial Results (Half Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.131.420 crores during the 6 Months period ended September 30, 2022 as compared to Rs.126.620 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.10.910 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.23.113 crores for the 6 Months period ended September 30, 2021.

The company has reported EPS of Rs.11.95 for the 6 Months period ended September 30, 2022 as compared to Rs.26.03 for the 6 Months period ended September 30, 2021.

Financials	Half Year Ended FY2023	Half Year Ended FY2022	% Change
Total Income	₹131.420 crs	₹126.620 crs	3.79%
Net Profit	₹10.910 crs	₹23.113 crs	-52.80%
EPS	₹11.95	₹26.03	-54.09%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 1995.55 as compared to the previous close of Rs. 1991.35. The total number of shares traded during the day was 168 in over 40 trades.

The stock hit an intraday high of Rs. 2009.00 and intraday low of 1978.10. The net turnover during the day was Rs. 335297.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q2FY23 H1FY23 ResultUpdate